Scarica l'app Stockscreener
3.25
6.21%
0.19
Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie
Nautilus Biotechnology (NAUT) price target increased by 60.00% to 4.08 - MSN
Here is why Nautilus Biotechnology (NAUT) is one of the best life sciences penny stocks to buy - MSN
Here is Why Nautilus Biotechnology (NAUT) is One of the Best Life Sciences Penny Stocks to Buy - Insider Monkey
How does Nautilus Biotechnology Inc compare to its peersProduct Launch & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Published on: 2026-04-11 15:42:56 - baoquankhu1.vn
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026 - Investing News Network
NAUT PE Ratio & Valuation, Is NAUT Overvalued - Intellectia AI
NAUT Technical Analysis & Stock Price Forecast - Intellectia AI
Published on: 2026-03-31 08:20:41 - baoquankhu1.vn
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - Sahm
Nautilus Biotechnology accelerates with Voyager Platform launch and first customer announcements - Traders Union
Nautilus Biotechnology at Investor Summit: Innovative Proteomics Pathway By Investing.com - Investing.com India
Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next Year - marketbeat.com
Nautilus Biotechnology (NASDAQ:NAUT) Sets New 52-Week HighWhat's Next? - MarketBeat
Aug Chart Watch: Is Nautilus Biotechnology Inc forming a breakout patternTrade Entry Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference - bitget.com
Nautilus management presents online March 25; webcast stays available - Stock Titan
Technical Analysis: Is Nautilus Biotechnology Inc stock a smart retirement pick2026 Earnings & Comprehensive Market Scan Insights - baoquankhu1.vn
If You Invested $1,000 in Nautilus Biotechnology Inc (NAUT) - Stock Titan
Published on: 2026-03-21 20:59:37 - baoquankhu1.vn
Baylor College of Medicine initiates research with Nautilus Biotechnology Voyager Platform - Traders Union
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform - Bitget
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program ... - Bluefield Daily Telegraph
Nautilus Biotechnology Announces Baylor College of Medicine - GlobeNewswire
What’s the MACD signal for Nautilus Biotechnology Inc.July 2025 Chart Watch & High Win Rate Trade Tips - mfd.ru
Aug Sectors: Is Nautilus Biotechnology Inc forming a breakout patternWeekly Investment Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Nautilus names Amber Faust VP of sales - The Pharma Letter
Sujal Patel Buys 25,000 Shares of Nautilus Biotechnology (NASDAQ:NAUT) Stock - MarketBeat
[Form 4] Nautilus Biotechnology, Inc. Insider Trading Activity - Stock Titan
Executive Parag Mallick receives 280,000 stock options at Nautilus (NAUT) - Stock Titan
Nautilus (NAUT) CEO Sujal Patel receives 650,000 stock option award - Stock Titan
Nautilus Biotechnology (NAUT) Chief People Officer granted 160,000 options - Stock Titan
Nautilus (NAUT) General Counsel receives 160,000-share stock option grant - Stock Titan
Nautilus Biotechnology appoints Amber Faust as VP of sales By Investing.com - Investing.com Canada
Nautilus Biotechnology names Amber Faust as Vice President of Sales to drive proteomics expansion - Traders Union
NAUT: New proteomics platform promises comprehensive, reproducible protein analysis with broad applications - TradingView
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales - BioSpace
Nautilus Biotechnology appoints proteomics commercial leader Amber Faust as vice president of sales - marketscreener.com
Nautilus Biotechnology appoints Amber Faust as VP of sales - Investing.com
Sales veteran joins Nautilus to push single-molecule proteomics into labs - Stock Titan
Guggenheim Forecasts Strong Price Appreciation for Nautilus Biotechnology (NASDAQ:NAUT) Stock - Defense World
Aug Big Picture: What are PROFs growth levers2025 EndofYear Setup & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
NAUT Should I Buy - Intellectia AI
Nautilus Biotechnology (NAUT) Target Price Raised by Guggenheim - GuruFocus
Nautilus debuts Voyager platform in push toward next-gen proteomics - Longevity.Technology
Nautilus Biotechnology (NASDAQ:NAUT) Price Target Raised to $4.00 at Guggenheim - MarketBeat
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2025 Earnings Call Transcript - Insider Monkey
Nautilus Biotechnology stock price target raised to $4 by Guggenheim - Investing.com Canada
Nautilus (NAUT) Q4 2025 Earnings Call Transcript - The Globe and Mail
Nautilus Biotechnology, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Nautilus Biotechnology Q4 Earnings Call Highlights - MarketBeat
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):